Global investigation and meta-analysis of the C9orf72 (G4C2)n repeat in Parkinson disease
Research output: Contribution to journal › Article
Standard
Global investigation and meta-analysis of the C9orf72 (G4C2)n repeat in Parkinson disease. / Theuns, J.; Verstraeten, A.; Sleegers, K.; Wauters, E.; Gijselinck, I.; Smolders, S.; Crosiers, D.; Corsmit, E.; Elinck, E.; Sharma, M.; Kruger, R.; Lesage, S.; Brice, A.; Chung, S. J.; Kim, M. J.; Kim, Y. J.; Ross, O. A.; Wszolek, Z. K.; Rogaeva, E.; Xi, Z.; Lang, A. E.; Klein, C.; Weissbach, A.; Mellick, G. D.; Silburn, P. A.; Hadjigeorgiou, G. M.; Dardiotis, E.; Hattori, N.; Ogaki, K.; Tan, E. K.; Zhao, Y.; Aasly, J.; Valente, E. M.; Petrucci, S.; Annesi, G.; Quattrone, A.; Ferrarese, C.; Brighina, L.; Deutschlander, A.; Puschmann, Andreas; Nilsson, C.; Garraux, G.; LeDoux, M. S.; Pfeiffer, R. F.; Boczarska-Jedynak, M.; Opala, G.; Maraganore, D. M.; Engelborghs, S.; De Deyn, P. P.; Cras, P.; Cruts, M.; Van Broeckhoven, C.
In: Neurology, Vol. 83, No. 21, 2014, p. 1906-13.Research output: Contribution to journal › Article
Harvard
APA
CBE
MLA
Vancouver
Author
RIS
TY - JOUR
T1 - Global investigation and meta-analysis of the C9orf72 (G4C2)n repeat in Parkinson disease
AU - Theuns, J.
AU - Verstraeten, A.
AU - Sleegers, K.
AU - Wauters, E.
AU - Gijselinck, I.
AU - Smolders, S.
AU - Crosiers, D.
AU - Corsmit, E.
AU - Elinck, E.
AU - Sharma, M.
AU - Kruger, R.
AU - Lesage, S.
AU - Brice, A.
AU - Chung, S. J.
AU - Kim, M. J.
AU - Kim, Y. J.
AU - Ross, O. A.
AU - Wszolek, Z. K.
AU - Rogaeva, E.
AU - Xi, Z.
AU - Lang, A. E.
AU - Klein, C.
AU - Weissbach, A.
AU - Mellick, G. D.
AU - Silburn, P. A.
AU - Hadjigeorgiou, G. M.
AU - Dardiotis, E.
AU - Hattori, N.
AU - Ogaki, K.
AU - Tan, E. K.
AU - Zhao, Y.
AU - Aasly, J.
AU - Valente, E. M.
AU - Petrucci, S.
AU - Annesi, G.
AU - Quattrone, A.
AU - Ferrarese, C.
AU - Brighina, L.
AU - Deutschlander, A.
AU - Puschmann, Andreas
AU - Nilsson, C.
AU - Garraux, G.
AU - LeDoux, M. S.
AU - Pfeiffer, R. F.
AU - Boczarska-Jedynak, M.
AU - Opala, G.
AU - Maraganore, D. M.
AU - Engelborghs, S.
AU - De Deyn, P. P.
AU - Cras, P.
AU - Cruts, M.
AU - Van Broeckhoven, C.
N1 - 21
PY - 2014
Y1 - 2014
N2 - OBJECTIVES: The objective of this study is to clarify the role of (G4C2)n expansions in the etiology of Parkinson disease (PD) in the worldwide multicenter Genetic Epidemiology of Parkinson's Disease (GEO-PD) cohort. METHODS: C9orf72 (G4C2)n repeats were assessed in a GEO-PD cohort of 7,494 patients diagnosed with PD and 5,886 neurologically healthy control individuals ascertained in Europe, Asia, North America, and Australia. RESULTS: A pathogenic (G4C2)n>60 expansion was detected in only 4 patients with PD (4/7,232; 0.055%), all with a positive family history of neurodegenerative dementia, amyotrophic lateral sclerosis, or atypical parkinsonism, while no carriers were detected with typical sporadic or familial PD. Meta-analysis revealed a small increase in risk of PD with an increasing number of (G4C2)n repeats; however, we could not detect a robust association between the C9orf72 (G4C2)n repeat and PD, and the population attributable risk was low. CONCLUSIONS: Together, these findings indicate that expansions in C9orf72 do not have a major role in the pathogenesis of PD. Testing for C9orf72 repeat expansions should only be considered in patients with PD who have overt symptoms of frontotemporal lobar degeneration/amyotrophic lateral sclerosis or apparent family history of neurodegenerative dementia or motor neuron disease.
AB - OBJECTIVES: The objective of this study is to clarify the role of (G4C2)n expansions in the etiology of Parkinson disease (PD) in the worldwide multicenter Genetic Epidemiology of Parkinson's Disease (GEO-PD) cohort. METHODS: C9orf72 (G4C2)n repeats were assessed in a GEO-PD cohort of 7,494 patients diagnosed with PD and 5,886 neurologically healthy control individuals ascertained in Europe, Asia, North America, and Australia. RESULTS: A pathogenic (G4C2)n>60 expansion was detected in only 4 patients with PD (4/7,232; 0.055%), all with a positive family history of neurodegenerative dementia, amyotrophic lateral sclerosis, or atypical parkinsonism, while no carriers were detected with typical sporadic or familial PD. Meta-analysis revealed a small increase in risk of PD with an increasing number of (G4C2)n repeats; however, we could not detect a robust association between the C9orf72 (G4C2)n repeat and PD, and the population attributable risk was low. CONCLUSIONS: Together, these findings indicate that expansions in C9orf72 do not have a major role in the pathogenesis of PD. Testing for C9orf72 repeat expansions should only be considered in patients with PD who have overt symptoms of frontotemporal lobar degeneration/amyotrophic lateral sclerosis or apparent family history of neurodegenerative dementia or motor neuron disease.
KW - Cohort Studies
KW - DNA Repeat Expansion/ genetics
KW - Female
KW - Humans
KW - Internationality
KW - Male
KW - Middle Aged
KW - Parkinson Disease/ diagnosis/epidemiology/ genetics
KW - Proteins/ genetics
U2 - 10.1212/wnl.0000000000001012
DO - 10.1212/wnl.0000000000001012
M3 - Article
VL - 83
SP - 1906
EP - 1913
JO - Neurology
JF - Neurology
SN - 1526-632X
IS - 21
ER -